Global Vaccine Safety

The 5th edition of the GVSI Bulletin available online

It includes a SEARO & WPRO regional update on the Intercountry workshop on Causality Assessment of AEFI held in Bangkok, a research study on improving global media monitoring - Pentavalent vaccine (DTP-HBV-Hib) and Sudden Infant Death Syndrome (SIDS) in India, a statement by the Global Advisory Committee on Vaccine Safety (GACVS) on the safety of HPV vaccines, an update on the Vaccine Safety Net and an introduction to the Vaccine Pharmacovigilance Toolkit.

Vaccine Safety Net

Ever wondered where to look for scientifically based information on the safety of vaccines on the internet?
WHO and partners established the Vaccine Safety Net project to facilitate the access of public health authorities, health professionals and the public to reliable information on vaccine safety.
Candidates interested in joining the VSN network may send their request for evaluation to the WHO Global Vaccine Safety team at
For details and list of VSN members websites, visit the VSN page:

Inter-country workshop on Causality Assessment of AEFI
18 – 20 February 2014 Bangkok

31 participants from Bangladesh, Bhutan, India, Indonesia, Maldives, Nepal, Sri Lanka, Thailand, Timor Leste and Vietnam participated in the first inter-country workshop that provided “hands on” training on the Revised WHO causality assessment methodology using cases from participating countries. Participants included EPI program managers, Epidemiologists, National Regulatory Authorities, clinical specialists, representatives from National Control Laboratories, National AEFI committees, Ministry of Health and WHO country office vaccine safety focal persons.

The workshop built national and regional capacity to investigate AEFI, assess causality, streamline AEFI data collection procedures and encouraged regional and global collaboration.

CIOMS Working Group on Vaccine Safety

The third meeting of the CIOMS working group on vaccine safety took place on 5-6 February 2014 in Atlanta. The meeting that was hosted by the US CDC, gathered 19 members from regulatory agencies, public health agencies, pharmaceutical companies and the WHO collaborating centre for international drug monitoring. The objective of the meeting was for members to agree upon the scope of work and to develop a work plan. The group decided to focus its efforts on three main topics:
1. Concepts for assessing pre and post-licensing vaccine safety information
2. Guidance for vaccine safety active surveillance
3. Guidance for vaccine safety crisis management.
The working group is expected to produce a series of consensus publications on the above topics.

GVSI highlights